Relmada Therapeutics, Inc. (RLMD)
7.03
+0.69
(+10.88%)
USD |
NASDAQ |
May 19, 16:00
7.035
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Shareholders Equity (Quarterly) : 218.73M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Theravance Biopharma, Inc. | 290.59M |
| AN2 Therapeutics, Inc. | 81.76M |
| Corcept Therapeutics, Inc. | 637.99M |
| Assertio Holdings, Inc. | 75.63M |
| Johnson & Johnson | 81.19B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 235.36M |
| Total Liabilities (Quarterly) | 16.63M |
| Current Ratio | 18.26 |